AtriCure develops and manufactures medical devices used in cardiac surgery, including systems for ablating heart tissue, closing the left atrial appendage, and managing atrial fibrillation through radiofrequency and cryoablation technologies. The company also produces devices for temporary nerve pain relief and supplies complementary surgical instruments and accessories. AtriCure sells its products to hospitals and medical centers globally through a combination of direct sales and independent distributors.

entry readiness 0 · NOT READY · exit proximity 35

Value area 25.36–55.47 · 2% of 120d volume overhead · clean runway